Proinflammatory Cytokine Effects on Mesenchymal Stem Cell Therapy for the Ischemic Heart

Rosamond, 2008, Heart disease and stroke statistics—2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee, Circulation, 117, e25, 10.1161/CIRCULATIONAHA.107.187998 Jolicoeur, 2007, Bringing cardiovascular cell-based therapy to clinical application: perspectives based on a National Heart, Lung, and Blood Institute Cell Therapy Working Group meeting, Am Heart J, 153, 732, 10.1016/j.ahj.2007.02.028 Kumar, 2008, Therapeutic potential of genetically modified mesenchymal stem cells, Gene Ther, 15, 711, 10.1038/gt.2008.35 Kestendjieva, 2008, Characterization of mesenchymal stem cells isolated from the human umbilical cord, Cell Biol Int, 32, 724, 10.1016/j.cellbi.2008.02.002 Amado, 2005, Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction, Proc Natl Acad Sci U S A, 102, 11474, 10.1073/pnas.0504388102 Kinnaird, 2004, Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms, Circ Res, 94, 678, 10.1161/01.RES.0000118601.37875.AC Berry, 2006, Mesenchymal stem cell injection after myocardial infarction improves myocardial compliance, Am J Physiol, 290, H2196 Iso, 2007, Multipotent human stromal cells improve cardiac function after myocardial infarction in mice without long-term engraftment, Biochem Biophys Res Commun, 354, 700, 10.1016/j.bbrc.2007.01.045 Carr, 2008, Bone marrow-derived stromal cells home to and remain in the infarcted rat heart but fail to improve function: an in vivo cine-MRI study, Am J Physiol, 295, H533 Grauss, 2007, Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction, Am J Physiol, 293, H2438 Grauss, 2008, Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts, Stem Cells, 26, 1083, 10.1634/stemcells.2007-0523 Abdel-Latif, 2007, Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis, Arch Intern Med, 167, 989, 10.1001/archinte.167.10.989 Stevens, 1954, Spontaneous testicular teratomas in an inbred strain of mice, Proc Natl Acad Sci U S A, 40, 1080, 10.1073/pnas.40.11.1080 Becker, 1963, Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells, Nature, 197, 452, 10.1038/197452a0 McCulloch, 2005, Perspectives on the properties of stem cells, Nat Med, 11, 1026, 10.1038/nm1005-1026 Christoforou, 2007, Stem cells and their potential in cell-based cardiac therapies, Prog Cardiovasc Dis, 49, 396, 10.1016/j.pcad.2007.02.006 Seydoux, 2006, Pathway to totipotency: lessons from germ cells, Cell, 127, 891, 10.1016/j.cell.2006.11.016 Filip, 2005, Stem cell plasticity and issues of stem cell therapy, Folia Biol (Praha), 51, 180 Sanchez, 2007, Present and future of stem cells for cardiovascular therapy, Ann Med, 39, 412, 10.1080/07853890701513746 Segers, 2008, Stem-cell therapy for cardiac disease, Nature, 451, 937, 10.1038/nature06800 Horwitz, 2005, Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement, Cytotherapy, 7, 393, 10.1080/14653240500319234 Dominici, 2006, Minimal criteria for defining multipotent mesenchymal stromal cells, Cytotherapy, 8, 315, 10.1080/14653240600855905 Kolf, 2007, Mesenchymal stromal cells, Arthritis Res Ther, 9, 204, 10.1186/ar2116 Haynesworth, 1996, Cytokine expression by human marrow-derived mesenchymal progenitor cells in vitro: effects of dexamethasone and IL-1 alpha, J Cell Physiol, 166, 585, 10.1002/(SICI)1097-4652(199603)166:3<585::AID-JCP13>3.0.CO;2-6 Caplan, 2006, Mesenchymal stem cells as trophic mediators, J Cell Biochem, 98, 1076, 10.1002/jcb.20886 Crisostomo, 2008, Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism, Am J Physiol, 294, C675, 10.1152/ajpcell.00437.2007 Crisostomo, 2007, Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kDa TNF receptor (TNFR1), J Mol Cell Cardiol, 42, 142, 10.1016/j.yjmcc.2006.09.016 Wang, 2006, Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism, Am J Physiol, 291, R880 Markel, 2008, VEGF is critical for stem cell-mediated cardioprotection and a crucial paracrine factor for defining the age threshold in adult and neonatal stem cell function, Am J Physiol Heart Circ Physiol, 295, H2308, 10.1152/ajpheart.00565.2008 Ryan, 2005, Mesenchymal stem cells avoid allogeneic rejection, J Inflamm (Lond), 2, 8, 10.1186/1476-9255-2-8 Minguell, 2006, Mesenchymal stem cells and the treatment of cardiac disease, Exp Biol Med (Maywood), 231, 39, 10.1177/153537020623100105 Atoui, 2008, Myocardial regenerative therapy: immunologic basis for the potential “universal donor cells”, Ann Thorac Surg, 86, 327, 10.1016/j.athoracsur.2008.03.038 Pittenger, 2004, Mesenchymal stem cells and their potential as cardiac therapeutics, Circ Res, 95, 9, 10.1161/01.RES.0000135902.99383.6f Saito, 2002, Xenotransplant cardiac chimera: immune tolerance of adult stem cells, Ann Thorac Surg, 74, 19, 10.1016/S0003-4975(02)03591-9 MacDonald, 2005, Persistence of marrow stromal cells implanted into acutely infarcted myocardium: observations in a xenotransplant model, J Thorac Cardiovasc Surg, 130, 1114, 10.1016/j.jtcvs.2005.04.033 Meirelles da Silva, 2003, Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization, Br J Haematol, 123, 702, 10.1046/j.1365-2141.2003.04669.x Caplan, 2001, Mesenchymal stem cells: building blocks for molecular medicine in the 21st century, Trends Mol Med, 7, 259, 10.1016/S1471-4914(01)02016-0 Alhadlaq, 2004, Mesenchymal stem cells: isolation and therapeutics, Stem Cells Dev, 13, 436, 10.1089/scd.2004.13.436 Teng, 2006, Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty, J Thorac Cardiovasc Surg, 132, 628, 10.1016/j.jtcvs.2006.05.034 Chachques, 2008, Myocardial Assistance by Grafting a New Bioartificial Upgraded Myocardium (MAGNUM trial): clinical feasibility study, Ann Thorac Surg, 85, 901, 10.1016/j.athoracsur.2007.10.052 Meldrum, 1998, Tumor necrosis factor in the heart, Am J Physiol, 274, R577 Sharma, 1997, Role of cytokines in myocardial ischemia and reperfusion, Mediators Inflamm, 6, 175, 10.1080/09629359791668 Meldrum, 1998, Human myocardial tissue TNFalpha expression following acute global ischemia in vivo, J Mol Cell Cardiol, 30, 1683, 10.1006/jmcc.1998.0776 Tashiro, 1995, Monocyte-related cytokines in acute myocardial infarction, Am Heart J, 130, 446, 10.1016/0002-8703(95)90350-X Deten, 2003, Differential cytokine expression in myocytes and non-myocytes after myocardial infarction in rats, Mol Cell Biochem, 242, 47, 10.1023/A:1021129410221 Latini, 1994, Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist, J Cardiovasc Pharmacol, 23, 1, 10.1097/00005344-199401000-00001 Bocker, 2008, IKK-2 is required for TNF-alpha-induced invasion and proliferation of human mesenchymal stem cells, J Mol Med, 86, 1183, 10.1007/s00109-008-0378-3 Sitcheran, 2003, NF-kappaB mediates inhibition of mesenchymal cell differentiation through a posttranscriptional gene silencing mechanism, Genes Dev, 17, 2368, 10.1101/gad.1114503 Guttridge, 2000, NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia, Science, 289, 2363, 10.1126/science.289.5488.2363 Markel, 2007, Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production, Am J Physiol, 293, G657 Rehman, 2004, Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells, Circulation, 109, 1292, 10.1161/01.CIR.0000121425.42966.F1 Pepper, 1997, Transforming growth factor-beta: vasculogenesis, angiogenesis, and vessel wall integrity, Cytokine Growth Factor Rev, 8, 21, 10.1016/S1359-6101(96)00048-2 Bao, 2007, TNFR gene-modified mesenchymal stem cells attenuate inflammation and cardiac dysfunction following MI, Scand Cardiovasc J, 1 Germani, 2007, Pivotal advances: high-mobility group box 1 protein—a cytokine with a role in cardiac repair, J Leukoc Biol, 81, 41, 10.1189/jlb.0306165 Meng, 2008, High mobility group box 1 protein inhibits the proliferation of human mesenchymal stem cells and promotes their migration and differentiation along osteoblastic pathway, Stem Cells Dev, 17, 805, 10.1089/scd.2007.0276 Yang, 2005, The cytokine activity of HMGB1, J Leukoc Biol, 78, 1, 10.1189/jlb.1104648 Chang, 2008, Impact of myocardial infarct proteins and oscillating pressure on the differentiation of mesenchymal stem cells: effect of acute myocardial infarction on stem cell differentiation, Stem Cells, 26, 1901, 10.1634/stemcells.2007-0708 Wang, 2008, Transforming growth factor-beta1 enhanced vascular endothelial growth factor synthesis in mesenchymal stem cells, Biochem Biophys Res Commun, 365, 548, 10.1016/j.bbrc.2007.11.014 Hermonat, 2007, Mechanism of action and delivery possibilities for TGFbeta1 in the treatment of myocardial ischemia, Cardiovasc Res, 74, 235, 10.1016/j.cardiores.2007.01.016 Lefer, 1990, Mediation of cardioprotection by transforming growth factor-beta, Science, 249, 61, 10.1126/science.2164258 Rosenkranz, 2004, TGF-beta1 and angiotensin networking in cardiac remodeling, Cardiovasc Res, 63, 423, 10.1016/j.cardiores.2004.04.030 Ross, 2008, How the Smads regulate transcription, Int J Biochem Cell Biol, 40, 383, 10.1016/j.biocel.2007.09.006 Derynck, 1998, Smads: transcriptional activators of TGF-beta responses, Cell, 95, 737, 10.1016/S0092-8674(00)81696-7 Dixon, 2000, Effect of chronic AT(1) receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters, Cardiovasc Res, 46, 286, 10.1016/S0008-6363(00)00035-3 Forte, 2006, Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation, Stem Cells, 24, 23, 10.1634/stemcells.2004-0176 Duan, 2003, Treatment of myocardial ischemia with bone marrow-derived mesenchymal stem cells overexpressing hepatocyte growth factor, Mol Ther, 8, 467, 10.1016/S1525-0016(03)00186-2 Davani, 2003, Insulin-like growth factor-1 protects ischemic murine myocardium from ischemia/reperfusion associated injury, Crit Care, 7, R176, 10.1186/cc2375 Li, 2007, Insulin-like growth factor 1 enhances the migratory capacity of mesenchymal stem cells, Biochem Biophys Res Commun, 356, 780, 10.1016/j.bbrc.2007.03.049 Haider, 2008, IGF-1-Overexpressing Mesenchymal Stem Cells Accelerate Bone Marrow Stem Cell Mobilization via Paracrine Activation of SDF-1{alpha}/CXCR4 Signaling to Promote Myocardial Repair, Circ Res, 103, 1300, 10.1161/CIRCRESAHA.108.186742 Guo, 2008, Insulin-like growth factor 1 improves the efficacy of mesenchymal stem cells transplantation in a rat model of myocardial infarction, J Biomed Sci, 15, 89, 10.1007/s11373-007-9207-x Haider, 2008, Strategies to promote donor cell survival: Combining preconditioning approach with stem cell transplantation, J Mol Cell Cardiol, 45, 554, 10.1016/j.yjmcc.2008.05.004 Gnecchi, 2006, Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement, Faseb J, 20, 661, 10.1096/fj.05-5211com Mirotsou, 2007, Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair, Proc Natl Acad Sci, 104, 1643, 10.1073/pnas.0610024104 Li, 2007, Bcl-2 engineered MSCs inhibited apoptosis and improved heart function, Stem Cells, 25, 2118, 10.1634/stemcells.2006-0771 Yang, 2007, Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction, Cardiology, 107, 17, 10.1159/000093609 Clerk, 2007, Signaling pathways mediating cardiac myocyte gene expression in physiological and stress responses, J Cell Physiol, 212, 311, 10.1002/jcp.21094